Influence of pyruvate on economy of contraction in isolated rabbit myocardium

European Journal of Heart Failure

Volumn 9, Issue 8, 2007, Pages 754-761

  Keweloh, Boris ^a,b   Janssen, Paul M L ^b   Siegel, Ulf ^b   Datz, Nicolin ^b   Zeitz, Oliver ^b   Hermann, Hans Peter ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Energetics; Heart failure; Inotropic therapy; Oxygen consumption; Pyruvate

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CYCLOPIAZONIC ACID; INOTROPIC AGENT; ISOPRENALINE; PYRUVIC ACID; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FEMALE; INDOLES; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; PYRUVIC ACID; RABBITS;

EID: 34547675937     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.03.011     Document Type: Article

References (39)

1. Lubsen J., Just H., Hjalmarsson A.C., et al. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial. Heart 76 (1996) 223-231
2. Uretsky B.F., Jessup M., Konstam M.A., et al. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation 82 (1990) 774-780
3. Hasenfuss G., Holubarsch C., Heiss H.W., et al. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. Circulation 80 (1989) 51-64
4. Hasenfuss G., Mulieri L.A., Allen P.D., Just H., and Alpert N.R. Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium. Circulation 94 (1996) 3155-3160
5. Colucci W.S., Wright R.F., and Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (first of two parts). New Engl J Med 314 (1986) 290-299
6. Colucci W.S., Wright R.F., and Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent developments (second of two parts). New Engl J Med 314 (1986) 349-358
7. Hermann H.P., Pieske B., Schwarzmuller E., Keul J., Just H., and Hasenfuss G. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet 353 (1999) 1321-1323
8. Hermann H.P., Arp J., Pieske B., et al. Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure. Eur J Heart Fail 6 (2004) 213-218
9. Bünger R., Mallet R.T., and Hartman A. Pyruvate enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. Eur J Biochem 180 (1988) 221-233
10. Liedtke A.J., and Nellis S.H. Effects of buffered pyruvate on regional cardiac function in moderate, short-term ischemia in swine heart. Circ Res 43 (1978) 189-199
11. (2+) in rabbit cardiac muscle preparations. Am J Physiol (Heart Circ Physiol) 279 2 (2000) H702-H708
12. Hermann H.P., Zeitz O., Lehnart S.E., et al. Potentition of β-adrenergic inotropic response by pyruvate in failing human myocardium. Cardiovasc Res 53 (2002) 116-123
13. Mentzer Jr. R.M., van Whylen D.G., Sodhi J., et al. Effect of pyruvate on regional ventricular function in normal and stunned myocardium. Ann Surg 209 (1989) 629-633
14. Yanos J., Patti M.J., and Stanko R.T. Hemodynamic effects of intravenous pyruvate in the intact, anesthetized dog. Crit Care Med 22 (1994) 844-850
15. Zweier J.L., and Jacobus W.E. Substrate induced alterations of high energy phosphate metabolism and contractile function in the perfused heart. J Biol Chem 262 (1987) 8015-8021
16. Mallet R.T., Sun J., Knott E.M., Sharma A.B., and Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med 230 (2005) 435-443
17. 2+ uptake. Biochim Biophys Acta 1224 (1994) 22-32
18. Martin B.J., Valdivia H.H., Bünger R., Lasley R.D., and Mentzer Jr. R.M. Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes. Am J Physiol (Heart Circ Physiol) 274 1 Pt 2 (1998) H8-H17
19. Hasenfuss G., Maier L.S., Hermann H.P., et al. Influence of pyruvate on contractile performance and Ca2+-cycling in isolated failing human myocardium. Circulation 105 (2002) 194-199
20. Laughlin M.R., and Heineman F.W. The relationship between phosphorylation potential and redox state in the isolated working rabbit heart. J Mol Cell Cardiol 26 (1994) 1525-1536
21. Scholz T.D., Laughlin M.R., Balaban R.S., Kupriyanov V.V., and Heineman F.W. Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts. Am J Physiol (Heart Circ Physiol) 268 (1995) H82-H91
22. (2+)-content in blunted inotropic responsiveness of failing human myocardium. J Mol Cell Cardiol 34 (2002) 455-467
23. De Boer R.A., Pinto Y.M., and Van Veldhuisen D.J. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 10 (2003) 113-126
24. Janssen P.M.L., Lehnart S.E., Prestle J., et al. The trabecula culture system: a novel technique to study contractile parameters over a multiday time period. Am J Physiol (Heart Circ Physiol) 274 (1998) H1481-H1488
25. ter Keurs H.E., Rijnsburger W.H., van Heuningen R., and Nagelsmit M.J. Tension development and sarcomere length in rat cardiac trabeculae: evidence of length-dependent activation. Circ Res 46 (1980) 703-714
26. Mulieri L.A., Hasenfuss G., Ittleman F., Blanchard E.M., and Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3 butanedione monoxime. Circ Res 65 (1989) 1441-1449
27. Janssen P.M.L., and de Tombe P.P. Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae. Am J Physiol (Heart Circ Physiol) 273 (1997) H2415-H2422
28. Meyer M., Keweloh B., Güth K., et al. Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations. J Mol Cell Cardiol 30 (1998) 1459-1470
29. Challoner D.R. Respiration in myocardium. Nature 217 (1968) 78-79
30. Mc Donald Jr. R.H. Developed tension: a major determinant of myocardial oxygen consumption. Am J Physiol 210 (1966) 351-356
31. Sarnoff S.J., Braunwald E., Welch G.H., Case R.B., Stainsby W.N., and Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 192 (1958) 148-156
32. Alpert N.R., Mulieri L.A., and Hasenfuss G. Myocardial chemo-mechanical energy transduction. The Heart and Cardiovascular System. second edition (1992), Raven Press Ltd, New York 111-128
33. 2+ content of rabbit ventricular muscle. Circ Res 73 (1993) 813-819
34. Poole R.C., Cranmer S.L., Halestrap A.P., and Levi A.J. Substrate and inhibitor specificity of monocarboxylate transport into heart cells and erythrocytes. Further evidence for the existence of two distinct carriers. Biochem J 269 (1990) 827-829
35. 2+ release in rats via mitochondria-dependent and -independent mechanisms. J Physiol 550 (2003) 765-783
36. 2+ mediated through alpha- and beta-adrenoceptors. Circ Res 62 (1988) 247-265
37. Kurihara S., and Konishi M. Effects of beta-adrenoceptor stimulation on intracellular Ca transients and tension in rat ventricular muscle. Pflügers Arch 409 (1987) 427-437
38. Suga H. Ventricular energetics. Physiol Rev 70 (1990) 247-277
39. Rapundalo S.T., Solaro R.J., and Kranias E.G. Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins. Circ Res 64 (1989) 104-111